Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-23-055664

Chief Executive Officer bought 150,000 shares at $0.92 ($137,970)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Collard Craig A Chief Executive Officer 2023-11-16 Purchase +150,000 $0.92 $137,970 186,496 D
Open-market purchases · 150,000 sh · avg $0.92 · $137,970
Loading xslF345X05/doc4.xml…